泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03347 泰格医药

已收盘 11-04 16:08:10

40.280

+2.420

+6.39%

最高40.500	最低36.680	成交量180.44万
今开37.520	昨收37.860	日振幅10.09%
总市值344.39亿	流通市值49.54亿	总股本8.55亿
成交额7,134万	换手率1.47%	流通股本1.23亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":40.28,"timestamp":1793779690007,"preClose":37.86,"halted":0,"volume":1804428,"delay":0,"changeRate":0.06391970417326999,"floatShares":123000000,"shares":855000000,"eps":1.223141113150999,"marketStatus":"已收盘","change":2.42,"latestTime":"11-04 16:08:10","open":37.52,"high":40.5,"low":36.68,"amount":71336799,"amplitude":0.100898,"askPrice":40.34,"askSize":1000,"bidPrice":40.28,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-0.5595788265860128,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793842200000},"marketStatusCode":5,"adr":0,"listingDate":1596729600000,"exchange":"SEHK","adjPreClose":37.86,"dividendRate":0.003681,"openAndCloseTimeList":[[1793755800000,1793764800000],[1793768400000,1793779200000]],"volumeRatio":1.393725,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":53.87,"timestamp":1793775600000,"preClose":50.13,"halted":0,"volume":14752200,"delay":0,"premium":"-36.42"}},"requestUrl":"/m/hq/s/03347","defaultTab":"news","newsList":[{"id":"1183719718","title":"泰格医药：摩根大通减持，好仓比例降至19.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183719718","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183719718?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:34","pubTimestamp":1793784898,"startTime":"0","endTime":"0","summary":"2026年10月30日，摩根大通依据证券借贷协议收回借出的8.90万股泰格医药H股。该操作属于证券借贷安排，并非在联交所公开市场直接买卖正股。摩根大通此次减持前持有泰格医药（03347）好仓2343.19万股，占比19.03%；减持后持股量为2342.61万股，好仓比例降至19.02%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141181549","title":"泰格医药：摩根大通减持，好仓比例降至19.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141181549","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141181549?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:24","pubTimestamp":1793784274,"startTime":"0","endTime":"0","summary":"2026年10月29日，摩根大通收回借出的泰格医药（03347）H股45.65万股。该操作属于证券借贷安排的股份收回，未通过联交所公开市场撮合，不属二级市场直接买卖。摩根大通此次减持前持有泰格医药好仓2356.79万，占比19.14%；减持后持股量为2343.19万，好仓比例降至19.03%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680020457","title":"生物医药板块盘初走高 百济神州（06160）涨4.66%、药明生物（02269）涨3.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680020457","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680020457?lang=zh_cn&edition=full","pubTime":"2026-11-04 09:53","pubTimestamp":1793757224,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块盘初走高，截至发稿，百济神州 涨4.66%，药明生物涨3.99%，荣昌生物涨3.60%，药明康德涨3.52%，康方生物涨3.37%，再鼎医药涨2.43%，复宏汉霖涨2.37%，药明合联涨2.05%，泰格医药涨1.58%。华安证券研究指出，2026年三季度，医药板块跑赢大市、利润逐季加速。展望后市，该机构预计CXO、创新药、医疗器械与低基数修复。血制品、品牌中药三季度收入仍在下降。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995176","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0140636845.USD","LU0229945570.USD","LU0516422952.EUR","02359","LU0052750758.USD","LU2045819591.USD","LU0348827113.USD","LU0029874905.USD","LU0979878070.USD","XBI","09995","LU1813983027.USD","KURE","LU1794554557.SGD","ONC","BK4585","02696","BK0239","LU0456846285.SGD","HK0000320223.HKD","LU0463099449.HKD","LU0823426480.USD","IE00BPRC5H50.USD","LU0455707207.USD","LU2778985437.USD","LU0469268626.HKD","LU0540923850.HKD","BK1589","09926","688235","BK1588","LU0417516738.SGD","IE00BFMHRM44.USD","161726","SG9999002463.SGD","LU0516422440.USD","LU0164880469.USD","03347","LU0211977185.USD","LU0029874061.USD","LU0348767384.USD","02268","LU1969619763.USD","06160","02269","LU0417516571.SGD","09688","399441","LU0543330566.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128003900","title":"泰格医药（03347）披露回购进展：已斥资8.24亿元回购约2096万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1128003900","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128003900?lang=zh_cn&edition=full","pubTime":"2026-11-03 18:18","pubTimestamp":1793701132,"startTime":"0","endTime":"0","summary":"2026年11月3日，泰格医药公告了截至2026年10月30日的股份回购进展情况。公司称，自回购专用证券账户于2026年内启动集中竞价交易以来，已累计回购公司A股20,963,478股，占公司目前总股本的2.4347%，占公司A股总股本的2.8410%。泰格医药将根据市场情况在回购期限内继续推进回购计划，并按规定及时披露后续进展。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130434495","title":"泰格医药10月股份变动月报：注销部分A股库存股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1130434495","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130434495?lang=zh_cn&edition=full","pubTime":"2026-11-03 16:44","pubTimestamp":1793695473,"startTime":"0","endTime":"0","summary":"杭州泰格医药科技股份有限公司于2026年11月3日发布2026年10月股份变动月报表，披露了公司A股及H股的注册股本和已发行股本变动情况。其中，A股注册股本由期初的人民币737,901,250元下降至人民币732,017,470元，主要原因是当月注销了合计5,883,780股A股库存股份。公告显示，公司自2024年至2026年分多次回购部分A股并将其作为库存股份，已于本月内先后在10月21日和10月28日分别注销合计5,883,780股A股库存股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680787743","title":"泰格医药：截至2026年10月30日公司累计回购股份2096.35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680787743","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680787743?lang=zh_cn&edition=full","pubTime":"2026-11-03 16:21","pubTimestamp":1793694060,"startTime":"0","endTime":"0","summary":"南财智讯11月3日电，泰格医药公告，截至2026年10月30日，公司通过回购专用证券账户以集中竞价交易方式回购股份2096.35万股，回购股数占公司目前总股本的2.43%，最高成交价为42.78元/股，最低成交价为38.22元/股，已使用资金总额为8.24亿元（不含交易费用）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611033920268341.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611033920268341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","BK0028","300347","BK1141","03347","BK0174","BK0216","LU1146622755.USD","BK0077","LU1820825898.SGD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680786971","title":"泰格医药（300347）10月30日主力资金净买入2241.86万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680786971","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680786971?lang=zh_cn&edition=full","pubTime":"2026-11-02 09:05","pubTimestamp":1793581539,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月30日收盘，泰格医药报收于49.67元，上涨3.07%，换手率3.0%，成交量16.83万手，成交额8.44亿元。近5日资金流向一览见下表：泰格医药融资融券信息显示，融资方面，当日融资买入3884.24万元，融资偿还4324.0万元，融资净偿还439.77万元。泰格医药主营业务：临床试验技术服务和临床试验相关服务及实验室服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200003253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","LU1820825898.SGD","BK0077","BK1576","BK1141","03347","BK1583","300347","BK0174","BK0028","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680620729","title":"股市必读：泰格医药三季报 - 第三季度单季净利润同比下降77.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680620729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680620729?lang=zh_cn&edition=full","pubTime":"2026-11-02 03:24","pubTimestamp":1793561055,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年第三季度单季度归母净利润1.41亿元，同比下降77.85%。业绩披露要点财务报告泰格医药2026年三季报显示，前三季度公司主营收入57.92亿元，同比上升15.23%；归母净利润-2.72亿元，同比下降126.66%；扣非净利润4.5亿元，同比上升38.08%；其中2026年第三季度，公司单季度主营收入20.84亿元，同比上升17.38%；单季度归母净利润1.41亿元，同比下降77.85%；单季度扣非净利润1.72亿元，同比上升49.62%；负债率16.88%，投资收益2932.85万元，财务费用6575.23万元，毛利率27.35%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200000859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","300347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679229572","title":"泰格医药（300347）2026年三季报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2679229572","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679229572?lang=zh_cn&edition=full","pubTime":"2026-10-31 11:52","pubTimestamp":1793418735,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期泰格医药发布2026年三季报。按单季度数据看，第三季度营业总收入20.84亿元，同比上升17.38%，第三季度归母净利润1.41亿元，同比下降77.85%。本报告期泰格医药公司应收账款体量较大，当期应收账款占最新年报归母净利润比达160.36%。本次财报公布的各项数据指标表现一般。去年的净利率为11.78%，算上全部成本后，公司产品或服务的附加值一般。本文数据来源于泰格医药2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100025500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","03347","BK1576","BK0174","BK1583","BK0216","LU1820825898.SGD","BK1141","BK0028","300347","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151583537","title":"泰格医药：摩根大通减持，好仓比例降至19.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=1151583537","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151583537?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:25","pubTimestamp":1793352315,"startTime":"0","endTime":"0","summary":"摩根大通于2026年10月27日以每股均价37.7263港元，场外卖出泰格医药（03347）股份49.09万股，涉资约1852.02万港元。该笔为场外交易（代价性质：现金），未经联交所公开市场撮合，不属二级市场直接买卖。摩根大通此次减持前持有泰格医药好仓2496.26万，占比20.27%；减持后持股量为2447.17万，好仓比例降至19.87%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679928238","title":"图解泰格医药三季报：第三季度单季净利润同比下降77.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679928238","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679928238?lang=zh_cn&edition=full","pubTime":"2026-10-30 02:46","pubTimestamp":1793299613,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药2026年三季报显示，前三季度公司主营收入57.92亿元，同比上升15.23%；归母净利润-2.72亿元，同比下降126.66%；扣非净利润4.5亿元，同比上升38.08%；其中2026年第三季度，公司单季度主营收入20.84亿元，同比上升17.38%；单季度归母净利润1.41亿元，同比下降77.85%；单季度扣非净利润1.72亿元，同比上升49.62%；负债率16.88%，投资收益2932.85万元，财务费用6575.23万元，毛利率27.35%。财报数据概要请见下图:本文数据来源于泰格医药2026年三季报，仅供参考不构成投资建议。相关 ETF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000005521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300347","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175818754","title":"泰格医药(03347)董事会审议通过三项议案 最高8亿元跨境资金池额度获批","url":"https://stock-news.laohu8.com/highlight/detail?id=1175818754","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175818754?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:35","pubTimestamp":1793270128,"startTime":"0","endTime":"0","summary":"2026年10月30日，泰格医药公告披露，公司第六届董事会第四次会议已于2026年10月29日在杭州召开。会议应到董事7人，实到7人，符合相关法律法规及公司章程要求。会议以现场与通讯相结合方式进行，审议并一致通过以下三项议案：。该议案以7票全票同意获得通过。公司表示，相关文件已同步在中国证监会创业板指定信息披露网站及深圳证券交易所网站发布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679847207","title":"泰格医药(03347)开展跨境资金池结算业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2679847207","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679847207?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:33","pubTimestamp":1793269984,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布公告，为使公司及子公司(含公司直接或间接持股的境内外全资、控股子公司)更高效地统筹境内外资金，进一步支持境外业务拓展，公司拟以泰格医药作为主办企业，在具备国际结算业务能力的银行开展跨境资金池结算业务。通过开展跨境资金池结算业务，公司及纳入资金池的境内外子公司将实现跨境人民币及外币资金的集中管理和统一调度，有效开展资金余缺调剂与归集，提升公司内部资金配置效率。此举有利于降低资金使用成本、提高资金使用效率，同时强化境外资金安全管控，优化整体业务流程，为公司境内外业务的协同发展提供更灵活高效的金融支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515285.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","LU1820825898.SGD","513105","300347","BK0077","BK0216","BK0028","LU1146622755.USD","510905","BK0174","BK1583","03347","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175126894","title":"泰格医药（03347）获准开展跨境资金池结算业务，额度不超过80,000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175126894","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175126894?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:31","pubTimestamp":1793269903,"startTime":"0","endTime":"0","summary":"2026年10月30日，泰格医药发布公告称，公司及董事会于2026年10月29日召开第六届董事会第四次会议，审议并通过《关于开展跨境资金池结算业务的议案》。根据决议，公司拟以杭州泰格医药科技股份有限公司为主办企业，在具备国际结算业务能力的银行开展跨境资金池结算业务，配套额度不超过80,000万元人民币或等值外币，该额度可在业务期限内循环使用。此次董事会决议文件已备查。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155103980","title":"泰格医药（03347）发布2026年第三季度报告：前三季度收入57.92亿元，同比增长15.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155103980","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155103980?lang=zh_cn&edition=full","pubTime":"2026-10-29 17:42","pubTimestamp":1793266934,"startTime":"0","endTime":"0","summary":"2026年10月29日，泰格医药披露2026年第三季度报告。报告显示，前三季度公司营业收入57.92亿元，同比增长15.23%；归属于上市公司股东的净亏损2.72亿元，同比下降126.66%。剔除非经常性损益后，归属于上市公司股东的扣非净利润为4.50亿元，同比增长38.08%。单季度来看，第三季度营业收入20.84亿元，同比增加17.38%；归属于上市公司股东的净利润1.41亿元，同比减少77.85%。当季扣非净利润1.72亿元，同比增长49.62%。报告期内经营活动产生的现金流量净额为7.71亿元，同比增长4.29%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679799424","title":"泰格医药(03347)前三季度归母净亏损2.72亿元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2679799424","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679799424?lang=zh_cn&edition=full","pubTime":"2026-10-29 17:38","pubTimestamp":1793266727,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布2026年前三季度业绩，该集团前三季度取得营业收入57.92亿元，同比增长15.23%;归母净亏损2.72亿元，同比盈转亏;每股基本亏损0.32元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515200.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0216","BK0028","LU1146622755.USD","BK1576","300347","BK1141","BK0174","BK1583","LU1820825898.SGD","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679648475","title":"泰格医药：Q3净利1.41亿元，同比下降77.85%，环比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2679648475","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679648475?lang=zh_cn&edition=full","pubTime":"2026-10-29 17:01","pubTimestamp":1793264516,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0174","BK1576","LU1820825898.SGD","BK1141","BK1583","BK0216","300347","LU1146622755.USD","BK0077","BK0028","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678462580","title":"小摩增持泰格医药(03347)约34.32万股 每股作价约37.64港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678462580","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678462580?lang=zh_cn&edition=full","pubTime":"2026-10-28 19:20","pubTimestamp":1793186417,"startTime":"0","endTime":"0","summary":"10月23日，小摩增持泰格医药(03347)34.3248万股，每股作价37.6383港元，总金额约为1291.93万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20261028/20261028192057_78282.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20261028/20261028192057_78282.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1514411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IE000M9KFDE8.USD","TFNS","IYF","LU0882574139.USD","BK1583","LU0868494708.USD","TRUF","BK4207","LU0048584097.USD","IE00B775SV38.USD","UYG","JPO","LU2168564222.USD","IXG","LU0345770308.USD","EWH","IE00BWXC8680.SGD","LU1145028129.USD","IE00B1BXHZ80.USD","LU0106261372.USD","LU2168563687.JPY","IE00BBT3K403.USD","LU2023250504.SGD","LU0640476718.USD","FTXO","300347","LU1988902786.USD","SG9999002232.USD","IYG","LU1116320901.HKD","VFH","LU1670627923.USD","FNCL","KBWB","LU2417539215.USD","LU2242649171.HKD","LU1064131342.USD","JPMO","IE00BHPRN162.USD","LU0820561909.HKD","LU2237443465.HKD","LU0234570918.USD","XLF","LU2054465674.USD","LU2552382058.USD","IE00BLSP4452.SGD","LU0320765646.SGD","LU1496350502.SGD","03347","LU2213496289.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173789335","title":"泰格医药完成约223万股回购注销 总股本降至8.55亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1173789335","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173789335?lang=zh_cn&edition=full","pubTime":"2026-10-28 17:11","pubTimestamp":1793178709,"startTime":"0","endTime":"0","summary":"2026年10月28日，杭州泰格医药科技股份有限公司披露，已完成部分回购股份的注销手续。注销规模：本次注销股份数量为2,228,580股，占注销前公司总股本的0.26%。注销金额：本次实际回购注销金额为108,923,785.11元。股本变动：注销后，公司总股本由857,370,850股减少至855,142,270股。公司表示，本次股份注销不会对财务状况和经营成果产生实质性影响，股份分布仍符合上市条件。后续公司将同步办理注册资本变更及章程修订等工商备案。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678617167","title":"张迎军2026年三季度表现，博道嘉兴一年持有期混合基金季度跌幅15.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678617167","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678617167?lang=zh_cn&edition=full","pubTime":"2026-10-27 19:27","pubTimestamp":1793100441,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2026年三季度末，基金经理张迎军旗下共管理9只基金，本季度表现最佳的为博道嘉兴一年持有期混合，季度净值跌15.56%。张迎军在担任博道嘉泰回报混合基金经理的任职期间累计任职回报125.95%，平均年化收益率为12.62%。持有期间的估算收益率为180.11%，持有期间通威股份在2020年到2021年的年报归属净利润增幅达124.76%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700037433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","03347","BK1583","BK1141"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tigermed.net","stockEarnings":[{"period":"1week","weight":0.0177},{"period":"1month","weight":-0.1748},{"period":"3month","weight":-0.0005},{"period":"6month","weight":-0.038},{"period":"1year","weight":-0.1848},{"period":"ytd","weight":-0.1059}],"compareEarnings":[{"period":"1week","weight":0.021},{"period":"1month","weight":-0.0186},{"period":"3month","weight":-0.0922},{"period":"6month","weight":-0.1164},{"period":"1year","weight":-0.1006},{"period":"ytd","weight":-0.0821}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州泰格医药科技股份有限公司是一家主要从事为新药研发提供临床试验全过程专业服务的中国公司。该公司提供服务主要包括临床试验技术服务和临床试验相关及实验室服务。临床试验技术服务提供创新药物、仿制药及医疗器械临床试验运营服务以及与临床试验直接相关的配套服务，包括临床运营、临床药理、注册与法规事务、科学事务等服务。临床试验相关及实验室服务提供在药物开发过程中的相关及实验室服务，包括数据管理及统计分析、临床试验现场管理、受试者招募、医学影像以及实验室等服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.032258},{"month":2,"riseRate":0.5,"avgChangeRate":0.003409},{"month":3,"riseRate":0.5,"avgChangeRate":-0.032695},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.051086},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.017912},{"month":6,"riseRate":0.666667,"avgChangeRate":0.042051},{"month":7,"riseRate":0.666667,"avgChangeRate":0.080461},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.061347},{"month":9,"riseRate":0.428571,"avgChangeRate":0.047335},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.049537},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.001399},{"month":12,"riseRate":0.5,"avgChangeRate":0.041242}],"exchange":"SEHK","name":"泰格医药","nameEN":"TIGERMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,03347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}